Market overview
The global pharmacy market is worth USD 2.0 tn in 2026 and is forecast to reach USD 3.2 tn by 2036, growing at a 5.0% CAGR. United States is the largest country market and Retail pharmacy chains is the largest by channel segment.
| Scope | Retail value of medicines dispensed and sold through community, hospital and online pharmacies, including prescription and over-the-counter products and related health items. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 1.9 tn |
| Value 2026 | USD 2.0 tn |
| Value 2036 | USD 3.2 tn |
| CAGR 2026-2036 | 5.0% |
| Volume 2026 | 49,412 million prescriptions |
| Volume 2036 | 66,027 million prescriptions |
| Average price 2026 | USD 40.4 per prescription |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Pharmacy market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 2.0 tn |
| 2027 | USD 2.1 tn |
| 2028 | USD 2.2 tn |
| 2029 | USD 2.3 tn |
| 2030 | USD 2.4 tn |
| 2031 | USD 2.5 tn |
| 2032 | USD 2.7 tn |
| 2033 | USD 2.8 tn |
| 2034 | USD 2.9 tn |
| 2035 | USD 3.1 tn |
| 2036 | USD 3.2 tn |
Pharmacy market segmentation
By channel
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Retail pharmacy chains | 46.0% | 42.0% | USD 918 bn | 4.0% |
| Independent pharmacies | 24.0% | 18.9% | USD 479 bn | 2.5% |
| Hospital pharmacy | 18.0% | 18.1% | USD 359 bn | 5.0% |
| Online and mail order | 12.0% | 21.0% | USD 239 bn | 11.1% |
By product
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Prescription medicines | 78.0% | 78.9% | USD 1.6 tn | 5.1% |
| Over-the-counter medicines | 12.0% | 11.0% | USD 239 bn | 4.1% |
| Other health products | 10.0% | 10.1% | USD 200 bn | 5.1% |
By ownership
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Chain-owned | 44.0% | 46.0% | USD 878 bn | 5.5% |
| Independent | 28.0% | 20.0% | USD 559 bn | 1.5% |
| Hospital-run | 18.0% | 18.0% | USD 359 bn | 5.0% |
| Cooperative and franchise | 10.0% | 16.0% | USD 200 bn | 10.1% |
By service
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Dispensing | 62.0% | 54.0% | USD 1.2 tn | 3.6% |
| Clinical and vaccination | 10.0% | 16.0% | USD 200 bn | 10.1% |
| Compounding | 6.0% | 6.0% | USD 120 bn | 5.0% |
| Retail wellness sales | 22.0% | 24.0% | USD 439 bn | 5.9% |
By payment
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Insurer or state reimbursed | 66.0% | 64.0% | USD 1.3 tn | 4.7% |
| Cash and out-of-pocket | 24.0% | 24.0% | USD 479 bn | 5.0% |
| Subscription and employer | 10.0% | 12.0% | USD 200 bn | 6.9% |
Top 25 countries for pharmacy by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 76.5% of 2026 revenue and the 25 countries below together hold 93.0%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 758 bn | 38.0% | USD 1.2 tn | 4.9% |
| 2 | China | USD 239 bn | 12.0% | USD 426 bn | 5.9% |
| 3 | Japan | USD 120 bn | 6.0% | USD 153 bn | 2.5% |
| 4 | Germany | USD 89.8 bn | 4.5% | USD 133 bn | 4.0% |
| 5 | France | USD 59.9 bn | 3.0% | USD 84.5 bn | 3.5% |
| 6 | India | USD 59.9 bn | 3.0% | USD 153 bn | 9.8% |
| 7 | United Kingdom | USD 55.9 bn | 2.8% | USD 81.2 bn | 3.8% |
| 8 | Italy | USD 49.9 bn | 2.5% | USD 68.2 bn | 3.2% |
| 9 | Brazil | USD 49.9 bn | 2.5% | USD 97.5 bn | 6.9% |
| 10 | Canada | USD 43.9 bn | 2.2% | USD 68.2 bn | 4.5% |
| 11 | Spain | USD 42.5 bn | 2.1% | USD 69.2 bn | 5.0% |
| 12 | Mexico | USD 42.5 bn | 2.1% | USD 69.2 bn | 5.0% |
| 13 | Australia | USD 36.7 bn | 1.8% | USD 52.0 bn | 3.5% |
| 14 | South Korea | USD 29.5 bn | 1.5% | USD 41.9 bn | 3.6% |
| 15 | Russia | USD 25.1 bn | 1.3% | USD 35.4 bn | 3.5% |
| 16 | Turkey | USD 21.9 bn | 1.1% | USD 43.9 bn | 7.2% |
| 17 | Netherlands | USD 19.6 bn | 1.0% | USD 27.6 bn | 3.5% |
| 18 | Indonesia | USD 17.6 bn | 0.9% | USD 35.4 bn | 7.3% |
| 19 | Poland | USD 16.2 bn | 0.8% | USD 32.2 bn | 7.1% |
| 20 | Saudi Arabia | USD 15.0 bn | 0.8% | USD 29.9 bn | 7.2% |
| 21 | Switzerland | USD 14.0 bn | 0.7% | USD 19.5 bn | 3.4% |
| 22 | Argentina | USD 13.0 bn | 0.7% | USD 26.0 bn | 7.2% |
| 23 | Thailand | USD 12.2 bn | 0.6% | USD 24.7 bn | 7.3% |
| 24 | Belgium | USD 11.6 bn | 0.6% | USD 16.2 bn | 3.5% |
| 25 | Egypt | USD 11.0 bn | 0.6% | USD 22.1 bn | 7.2% |
| Rest of world | USD 141 bn | 7.0% | USD 215 bn | 4.3% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- CVS Health
- Walgreens Boots Alliance
- Cardinal Health
- McKesson
- Cencora
- Walmart
- Amazon Pharmacy
- Optum Rx
Group 2: Regional and specialist players
- Alliance Healthcare
- Zur Rose
- Shoppers Drug Mart
- Kroger
- Phoenix Group
- Shop Apotheke
- Raia Drogasil
- Matsumoto Kiyoshi
- Chemist Warehouse
Group 3: Emerging and niche players
- Apollo Pharmacy
- 1mg
- PharmEasy
- Netmeds
- MedPlus
- Capsule
- Alto Pharmacy
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the pharmacy market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 5.0% is calculated from the resulting values.
The market is divided by channel, by product, by ownership, by service, by payment. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the pharmacy market?
The global pharmacy market is estimated at USD 1.9 tn in 2025 and USD 2.0 tn in 2026.
How fast will the pharmacy market grow?
It is forecast to reach USD 3.2 tn by 2036, a compound annual growth rate of 5.0% from 2026, an increase of USD 1.3 tn.
Which country is the largest market for pharmacy?
United States is the largest market by revenue at USD 758 bn in 2026, 38.0% of the global total. The three largest countries together hold 56.0%.
Which country is growing fastest?
Among the ten largest markets, India is growing fastest at 9.8% a year from 2026 to 2036.
Which pharmacy segment is largest?
In the by channel split, Retail pharmacy chains is the largest segment with 46.0% of 2026 revenue.
Who are the leading pharmacy companies?
Global leaders include CVS Health, Walgreens Boots Alliance, Cardinal Health, McKesson.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- PharmaceuticalsUSD 1.8 tn · 6.0% CAGR
- Pharmaceutical DistributionUSD 1.6 tn · 5.5% CAGR
- Health InsuranceUSD 2.5 tn · 6.0% CAGR
- Drug StoreUSD 1.4 tn · 4.5% CAGR
- Long Term CareUSD 1.0 tn · 5.5% CAGR
- Small Molecule DrugsUSD 1.0 tn · 5.0% CAGR
- Medical DevicesUSD 675 bn · 5.5% CAGR
- TabletUSD 580 bn · 5.5% CAGR